New trends in the diagnosis and treatment of renal cell carcinoma

Keyphrases

• Renal Cell Carcinoma 100%
• Therapeutic Vaccine 66%
• Laparoscopic Partial Nephrectomy 66%
• Combined Treatment 33%
• Renal Carcinoma Cells 33%
• Metastatic Renal Cell Carcinoma (mRCC) 33%
• Standard of Care 33%
• Specific Marker 33%
• Localized Disease 33%
• Adrenalectomy 33%
• Human Tumor Cells 33%
• Experimental Therapeutics 33%
• Hybrid Vaccine 33%
• Cell Hybrid 33%
• Contralateral Kidney 33%
• Tumor-infiltrating Lymphocytes 33%
• Radical Nephrectomy 33%
• Tolerogenic Dendritic Cells 33%
• Localized Renal Cell Carcinoma 33%
• Partial Nephrectomy 33%
• Kidney Surgery 33%
• TNM Classification 33%
• Cytoreductive Nephrectomy 33%
• Small Renal Mass 33%
• Ablative Surgery 33%
• G250 33%

Medicine and Dentistry

• Clear Cell Renal Cell Carcinoma 100%
• Immunotherapy 40%
• Radical Nephrectomy 40%
• Partial Nephrectomy 40%
• Tumor Vaccine 40%
• Contralateral 20%
• Kidney Metastasis 20%
• Adrenalectomy 20%
• Cancer Staging 20%
• Ablation Therapy 20%
• Kidney Tumour 20%
• Localized Disease 20%
• Carcinoma Cell 20%
• Autologous Tumor Cell 20%
• Dendritic Cell 20%
• Experimental Therapy 20%
• Tumor Infiltrating Lymphocyte 20%
• Nephrectomy 20%
• Kidney Surgery 20%